Cargando…

LV Dyssynchrony Assessed With Phase Analysis on Gated Myocardial Perfusion SPECT Can Predict Response to CRT in Patients With End-Stage Heart Failure

BACKGROUND: Cardiac resynchronization therapy (CRT) is an established treatment in patients with end-stage heart failure and wide QRS complex. However, about 30% of patients do not benefit from CRT (non-responder). Recent studies with tissue Doppler imaging yielded disappointing results in predictin...

Descripción completa

Detalles Bibliográficos
Autores principales: Azizian, Nasrin, Rastgou, Fereydoon, Ghaedian, Tahereh, Golabchi, Allahyar, Bahadorian, Behdad, Khanlarzadeh, Vida, Azizian, Zahra, Haghjoo, Majid
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Kowsar 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4347800/
https://www.ncbi.nlm.nih.gov/pubmed/25785250
http://dx.doi.org/10.5812/cardiovascmed.20720
_version_ 1782359866771243008
author Azizian, Nasrin
Rastgou, Fereydoon
Ghaedian, Tahereh
Golabchi, Allahyar
Bahadorian, Behdad
Khanlarzadeh, Vida
Azizian, Zahra
Haghjoo, Majid
author_facet Azizian, Nasrin
Rastgou, Fereydoon
Ghaedian, Tahereh
Golabchi, Allahyar
Bahadorian, Behdad
Khanlarzadeh, Vida
Azizian, Zahra
Haghjoo, Majid
author_sort Azizian, Nasrin
collection PubMed
description BACKGROUND: Cardiac resynchronization therapy (CRT) is an established treatment in patients with end-stage heart failure and wide QRS complex. However, about 30% of patients do not benefit from CRT (non-responder). Recent studies with tissue Doppler imaging yielded disappointing results in predicting CRT responders. Phase analysis was developed to allow assessment of LV dyssynchrony by gated single photon emission computed tomography (SPECT) myocardial perfusion imaging (GMPS). OBJECTIVES: The aim of present study was to investigate the role of quantitative GMPS-derived LV dyssynchrony data to predict CRT responder. PATIENTS AND METHODS: Thirty eligible patients for CRT implantation underwent GMPS and echocardiography. Response to CRT was evaluated six months after the device implantation. Clinical response to CRT was defined as 50 meters increase in 6-minute walking test (6-MWT) distance. Echocardiographic response to CRT was defined as ≥ 15% decrease in left ventricular end-systolic volume (LVESV). The lead position was considered concordant if it was positioned at the area of latest mechanical activation, and discordant if located outside the area of latest mechanical activation. RESULTS: Clinical response to CRT was observed in 74% of patients. However, only 57% of patients were responder according to the echo criteria. There were statistically significant differences between CRT responders and non-responders for GMPS-derived variables, including phased histogram bandwidth (PHB), phase SD (PSD), and Entropy. Moreover, a cutoff value of 112° for PHB with a sensitivity of 72% and specificity of 70%, a cutoff value of 21° for PSD with a sensitivity of 90% and specificity of 74%, and a cutoff of 52% for Entropy with a sensitivity of 90% and a specificity of 80% were considered to discriminate responders and non-responders. CRT response was more likely in patients with concordant LV lead position compared to those with discordant LV lead position. CONCLUSIONS: GMPS-derived LV dyssynchrony variables can predict response to CRT with good sensitivity and specificity.
format Online
Article
Text
id pubmed-4347800
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher Kowsar
record_format MEDLINE/PubMed
spelling pubmed-43478002015-03-17 LV Dyssynchrony Assessed With Phase Analysis on Gated Myocardial Perfusion SPECT Can Predict Response to CRT in Patients With End-Stage Heart Failure Azizian, Nasrin Rastgou, Fereydoon Ghaedian, Tahereh Golabchi, Allahyar Bahadorian, Behdad Khanlarzadeh, Vida Azizian, Zahra Haghjoo, Majid Res Cardiovasc Med Research Article BACKGROUND: Cardiac resynchronization therapy (CRT) is an established treatment in patients with end-stage heart failure and wide QRS complex. However, about 30% of patients do not benefit from CRT (non-responder). Recent studies with tissue Doppler imaging yielded disappointing results in predicting CRT responders. Phase analysis was developed to allow assessment of LV dyssynchrony by gated single photon emission computed tomography (SPECT) myocardial perfusion imaging (GMPS). OBJECTIVES: The aim of present study was to investigate the role of quantitative GMPS-derived LV dyssynchrony data to predict CRT responder. PATIENTS AND METHODS: Thirty eligible patients for CRT implantation underwent GMPS and echocardiography. Response to CRT was evaluated six months after the device implantation. Clinical response to CRT was defined as 50 meters increase in 6-minute walking test (6-MWT) distance. Echocardiographic response to CRT was defined as ≥ 15% decrease in left ventricular end-systolic volume (LVESV). The lead position was considered concordant if it was positioned at the area of latest mechanical activation, and discordant if located outside the area of latest mechanical activation. RESULTS: Clinical response to CRT was observed in 74% of patients. However, only 57% of patients were responder according to the echo criteria. There were statistically significant differences between CRT responders and non-responders for GMPS-derived variables, including phased histogram bandwidth (PHB), phase SD (PSD), and Entropy. Moreover, a cutoff value of 112° for PHB with a sensitivity of 72% and specificity of 70%, a cutoff value of 21° for PSD with a sensitivity of 90% and specificity of 74%, and a cutoff of 52% for Entropy with a sensitivity of 90% and a specificity of 80% were considered to discriminate responders and non-responders. CRT response was more likely in patients with concordant LV lead position compared to those with discordant LV lead position. CONCLUSIONS: GMPS-derived LV dyssynchrony variables can predict response to CRT with good sensitivity and specificity. Kowsar 2014-11-25 /pmc/articles/PMC4347800/ /pubmed/25785250 http://dx.doi.org/10.5812/cardiovascmed.20720 Text en Copyright © 2014, Rajaie Cardiovascular Medical and Research Center, Iran University of Medical Sciences. http://creativecommons.org/licenses/by-nc/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
spellingShingle Research Article
Azizian, Nasrin
Rastgou, Fereydoon
Ghaedian, Tahereh
Golabchi, Allahyar
Bahadorian, Behdad
Khanlarzadeh, Vida
Azizian, Zahra
Haghjoo, Majid
LV Dyssynchrony Assessed With Phase Analysis on Gated Myocardial Perfusion SPECT Can Predict Response to CRT in Patients With End-Stage Heart Failure
title LV Dyssynchrony Assessed With Phase Analysis on Gated Myocardial Perfusion SPECT Can Predict Response to CRT in Patients With End-Stage Heart Failure
title_full LV Dyssynchrony Assessed With Phase Analysis on Gated Myocardial Perfusion SPECT Can Predict Response to CRT in Patients With End-Stage Heart Failure
title_fullStr LV Dyssynchrony Assessed With Phase Analysis on Gated Myocardial Perfusion SPECT Can Predict Response to CRT in Patients With End-Stage Heart Failure
title_full_unstemmed LV Dyssynchrony Assessed With Phase Analysis on Gated Myocardial Perfusion SPECT Can Predict Response to CRT in Patients With End-Stage Heart Failure
title_short LV Dyssynchrony Assessed With Phase Analysis on Gated Myocardial Perfusion SPECT Can Predict Response to CRT in Patients With End-Stage Heart Failure
title_sort lv dyssynchrony assessed with phase analysis on gated myocardial perfusion spect can predict response to crt in patients with end-stage heart failure
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4347800/
https://www.ncbi.nlm.nih.gov/pubmed/25785250
http://dx.doi.org/10.5812/cardiovascmed.20720
work_keys_str_mv AT aziziannasrin lvdyssynchronyassessedwithphaseanalysisongatedmyocardialperfusionspectcanpredictresponsetocrtinpatientswithendstageheartfailure
AT rastgoufereydoon lvdyssynchronyassessedwithphaseanalysisongatedmyocardialperfusionspectcanpredictresponsetocrtinpatientswithendstageheartfailure
AT ghaediantahereh lvdyssynchronyassessedwithphaseanalysisongatedmyocardialperfusionspectcanpredictresponsetocrtinpatientswithendstageheartfailure
AT golabchiallahyar lvdyssynchronyassessedwithphaseanalysisongatedmyocardialperfusionspectcanpredictresponsetocrtinpatientswithendstageheartfailure
AT bahadorianbehdad lvdyssynchronyassessedwithphaseanalysisongatedmyocardialperfusionspectcanpredictresponsetocrtinpatientswithendstageheartfailure
AT khanlarzadehvida lvdyssynchronyassessedwithphaseanalysisongatedmyocardialperfusionspectcanpredictresponsetocrtinpatientswithendstageheartfailure
AT azizianzahra lvdyssynchronyassessedwithphaseanalysisongatedmyocardialperfusionspectcanpredictresponsetocrtinpatientswithendstageheartfailure
AT haghjoomajid lvdyssynchronyassessedwithphaseanalysisongatedmyocardialperfusionspectcanpredictresponsetocrtinpatientswithendstageheartfailure